Glaucoma Archives - MPR

Glaucoma

Sepetaprost Effective and Safe in Glaucoma, Ocular Hypertension

This article is part of MPR’s coverage of the American Academy of Ophthalmology 2019 Meeting, taking place in San Francisco, CA. Our staff will report on medical research related to eye disorders, conducted by experts in the field. Check back regularly for more news from AAO 2019. SAN FRANCISCO – Sepetaprost 0.002% was found to…

FDA to Review Bimatoprost SR Implant for IOP Reduction in Glaucoma, Ocular HTN

The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for bimatoprost sustained-release (SR; Allergan), a first-in-class biodegradable implant, for the reduction of intraocular pressure (IOP) in patients with primary open-angle glaucoma or ocular hypertension. The NDA includes data from two phase 3 studies (NCT02250651, NCT02247804) that evaluated the efficacy…